HTB homepage • Conference reports • Articles by subject • Subscribe May 2003 Contents Editorial Volume 4 Number 4 May 2003 Conference reports 4th International Workshop on Clinical Pharmacology of HIV Therapy, 27-29 March 2003, Cannes, France Can low NVP plasma concentrations explain the results seen in the EFV and NVP containing arms of the NARVAL study? Up to one third of patients receiving standard doses of NNRTIs may be being underdosed Nelfinavir concentrations are significantly higher in HIV/HCV co-infected patients with cirrhosis Less diarrhoea and bioequivalence with the new nelfinavir 625mg tablet The potential for probenecid to have a serious interaction with HIV-1 protease inhibitors PK studies reveal significant sex/gender differences Pregnancy-related PK studies New test to measure intracellular levels of nucleosides Case studies for therapeutic drug monitoring (TDM) Launch of guide to the use of drug level monitoring 10th Conference on Retroviruses and Opportunistic Infections (CROI), 10-14 February 2003, Boston, USA Pharmacokinetic papers from 10th CROI Pediatric studies from 10th CROI Antiretrovirals T-20 access programme to continue in UK for a further two months Durability and success capability of HAART: 4.5 years follow-up Older HIV-positive patients in the era of HAART: changing of a scenario Immune reconstitution in older HIV-positive individuals Treatment access The City turns up the heat on drug companies to make treatment available in poorest countries Lancet commentary concludes that prevention and treatment in South Africa are affordable and desirable South Africa treatment protests go global Gilead to sell tenofovir at cost to 68 countries New advocacy coalition demands emergency funding from rich governments for Global Fund Weight, diabetes, metabolic complications Statins and fibrates both relatively effective for PI-induced hyperlipidemia Pioglitazone subjectively improves body shape abnormalities Hepatitis coinfection BHIVA HIV/hepatitis B and HIV/hepatitis C co-infection guidelines (2003): posted to web for consultation Index of biochemical markers could reduce need for biopsy by half in HIV/HCV co-infected patients HCV protects against abnormal blood lipids in HAART-treated HIV patients HCV levels in semen Basic science and immunology Tissue T-cell analysis represents renewed challenge to ‘tap and drain’ orthodoxy Drug resistance Study reveals new reverse transcriptase mutations Nutrition Integrating nutrition therapy into medical management of HIV: a supplement of Clinical Infectious Diseases On the web 38th Annual Meeting of the European Association for the Study of the Liver (EASL) First European HIV Drug Resistance Workshop Further Coverage of 10th Retrovirus Conference Medscape articles Newsletters and journals: IAPAC Monthly, AIDS Treatment News, STEP Perspective, PRN Notebook, Hopkins HIV Report, GHMC Treatment Issues, TAG Line Nutritional Care Manual for HIV-positive people PDFs Volume 4 Number 4 May 2003 PDF HTB homepage • Conference reports • Articles by subject • Subscribe
